Why does Japan have so few cases of COVID19?
Identifieur interne : 000063 ( 2020/Analysis ); précédent : 000062; suivant : 000064Why does Japan have so few cases of COVID19?
Auteurs : Akiko Iwasaki [États-Unis] ; Nathan D. Grubaugh [États-Unis]Source :
- EMBO molecular medicine [ 1757-4684 ] ; 2020.
Abstract
There is a lot of interest brewing as to why Japan has such low numbers of confirmed infected cases of the COVID19 disease, caused by the SARS-COV-2 virus (Figure. 1), despite its high population density (over 6,100 persons/sqkm in Tokyo, 2.4 times higher than New York City) and large percentage of high-risk individuals over 65 years of age (about 26%, compared with 15% in the USA). In Singapore and Hong Kong, rapid and strict quarantine rules and contact tracing has helped to "flatten the curve".
DOI: 10.15252/emmm.202012481
PubMed: 32275804
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000233
- to stream PubMed, to step Curation: 000233
- to stream PubMed, to step Checkpoint: 000048
- to stream Ncbi, to step Merge: 003879
- to stream Ncbi, to step Curation: 003879
- to stream Ncbi, to step Checkpoint: 003879
- to stream Main, to step Merge: 000063
- to stream Main, to step Curation: 000063
- to stream Main, to step Exploration: 000063
- to stream 2020, to step Extraction: 000063
Links to Exploration step
pubmed:32275804Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Why does Japan have so few cases of COVID19?</title><author><name sortKey="Iwasaki, Akiko" sort="Iwasaki, Akiko" uniqKey="Iwasaki A" first="Akiko" last="Iwasaki">Akiko Iwasaki</name><affiliation wicri:level="2"><nlm:affiliation>Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Grubaugh, Nathan D" sort="Grubaugh, Nathan D" uniqKey="Grubaugh N" first="Nathan D" last="Grubaugh">Nathan D. Grubaugh</name><affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32275804</idno><idno type="pmid">32275804</idno><idno type="doi">10.15252/emmm.202012481</idno><idno type="wicri:Area/PubMed/Corpus">000233</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000233</idno><idno type="wicri:Area/PubMed/Curation">000233</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000233</idno><idno type="wicri:Area/PubMed/Checkpoint">000048</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000048</idno><idno type="wicri:Area/Ncbi/Merge">003879</idno><idno type="wicri:Area/Ncbi/Curation">003879</idno><idno type="wicri:Area/Ncbi/Checkpoint">003879</idno><idno type="wicri:Area/Main/Merge">000063</idno><idno type="wicri:Area/Main/Curation">000063</idno><idno type="wicri:Area/Main/Exploration">000063</idno><idno type="wicri:Area/2020/Extraction">000063</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Why does Japan have so few cases of COVID19?</title><author><name sortKey="Iwasaki, Akiko" sort="Iwasaki, Akiko" uniqKey="Iwasaki A" first="Akiko" last="Iwasaki">Akiko Iwasaki</name><affiliation wicri:level="2"><nlm:affiliation>Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Grubaugh, Nathan D" sort="Grubaugh, Nathan D" uniqKey="Grubaugh N" first="Nathan D" last="Grubaugh">Nathan D. Grubaugh</name><affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author></analytic><series><title level="j">EMBO molecular medicine</title><idno type="eISSN">1757-4684</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is a lot of interest brewing as to why Japan has such low numbers of confirmed infected cases of the COVID19 disease, caused by the SARS-COV-2 virus (Figure. 1), despite its high population density (over 6,100 persons/sqkm in Tokyo, 2.4 times higher than New York City) and large percentage of high-risk individuals over 65 years of age (about 26%, compared with 15% in the USA). In Singapore and Hong Kong, rapid and strict quarantine rules and contact tracing has helped to "flatten the curve".</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Connecticut</li></region></list><tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Iwasaki, Akiko" sort="Iwasaki, Akiko" uniqKey="Iwasaki A" first="Akiko" last="Iwasaki">Akiko Iwasaki</name></region><name sortKey="Grubaugh, Nathan D" sort="Grubaugh, Nathan D" uniqKey="Grubaugh N" first="Nathan D" last="Grubaugh">Nathan D. Grubaugh</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000063 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000063 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32275804
|texte= Why does Japan have so few cases of COVID19?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32275804" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |